| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $9.5B | $9.3B | $8.5B | $8.1B | $7.8B | $6.7B | $1.7B | $1.6B |
| Cost of Revenue | $2.7B | $2.7B | $2.6B | $2.5B | $2.3B | $2.1B | $2.0B | $1.9B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $2.4B | $2.3B | $2.2B | $2.0B | $2.0B | $1.7B | $1.6B | $1.5B |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $2.7B | $2.5B | $2.3B | $2.1B | $2.0B | $1.6B | $0.4B | $0.3B |
| EPS (Basic) | $6.03 | $5.47 | $5.08 | $4.51 | $4.29 | $3.44 | $0.81 | $0.72 |
| EPS (Diluted) | $6.02 | $5.47 | $5.07 | $4.49 | $4.27 | $3.42 | $0.80 | $0.71 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $15.5B | $14.2B | $14.3B | $14.9B | $13.9B | $13.6B | $11.5B | $10.8B |
| Current Assets | $6.8B | $6.0B | $6.3B | $7.5B | $6.9B | $6.6B | $4.7B | $4.4B |
| Cash & Equivalents | — | — | — | — | — | — | — | — |
| Total Liabilities | $12.1B | $9.5B | $9.3B | $10.5B | $9.4B | $9.8B | $8.8B | $8.6B |
| Current Liabilities | $2.2B | $3.4B | $1.9B | $3.2B | $1.8B | $2.2B | $1.8B | $1.2B |
| Stockholders' Equity | $3.3B | $4.8B | $5.0B | $4.4B | $4.5B | $3.8B | — | $2.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.9B | $3.0B | $2.4B | $1.9B | $2.2B | $2.1B | $1.8B | $1.8B |
| Investing Cash Flow | $-0.7B | $-0.3B | $-0.8B | $-0.9B | $-0.5B | $-0.6B | $-0.5B | $-2.3B |
| Capital Expenditures | $0.6B | $0.7B | $0.7B | $0.6B | $0.5B | $0.5B | $0.5B | $0.3B |
| Financing Cash Flow | $-1.9B | $-2.7B | $-3.1B | $-0.9B | $-1.9B | $0.1B | $-1.0B | $0.5B |